Epstein-Barr virus infection mechanisms

Chinese Journal of Cancer

Volumn 33, Issue 11, 2014, Pages 545-548

  Chesnokova, Liudmila S ^a   Hutt Fletcher, Lindsey M ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

complement receptor type 2; Entry; Glycoproteins; HLA class II; Integrins

Indexed keywords

CELL PROTEIN; COMPLEMENT COMPONENT C3D RECEPTOR; COMPLEMENT RECEPTOR; COMPLEMENT RECEPTOR TYPE 2; HLA ANTIGEN CLASS 2; INTEGRIN; MICROSOMAL AMINOPEPTIDASE; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS FUSION PROTEIN; VIRUS GLYCOPROTEIN; VIRAL PROTEIN;

B LYMPHOCYTE; CYTOPLASM; ENDOCYTOSIS; EPITHELIUM CELL; EPSTEIN BARR VIRUS INFECTION; HUMAN; NONHUMAN; PH; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS TRANSMISSION; EPSTEIN BARR VIRUS; VIRAL PHENOMENA AND FUNCTIONS;

B-LYMPHOCYTES; EPITHELIAL CELLS; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; VIRAL PROTEINS; VIRUS PHYSIOLOGICAL PHENOMENA;

EID: 84909951151     PISSN: 1000467X     EISSN: 1944446X     Source Type: Journal    
DOI: 10.5732/cjc.014.10168     Document Type: Review

References (37)

1. Shannon-Lowe CD, Neuhierl B, Baldwin G, et al. Resting B cells as a transfer vehicle for Epstein-Barr virus infection of epithelial cells. Proc Natl Acad Sci U S A, 2006,103:7065-7070.
2. Tugizov SM, Herrera R, Veluppillai P, et al. Epstein-Barr virus (EBV)- infected monocytes facilitate dissemination of EBV within the oral mucosal epithelium. J Virol, 2007,81:5484-5496.
3. Tugizov SM, Herrera R, Palefsky JM. Epstein-Barr virus transcytosis through plarized oral epithelial cells. J Virol, 2013,87:8179-8194.
4. Hutt-Fletcher LM. Epstein-Barr virus entry. J Virol, 2007,81:7825-7832.
5. Spear PG, Longnecker R. Herpesvirus entry: an update. J Virol, 2003,77:10179-10185.
6. Connolly SA, Jackson JO, Jardetzky TS, et al. Fusing structure and function: a structural view of the herpesvirus entry machinery. Nat Rev Microbiol, 2011,9:369-381.
7. Sorem J, Jardetzky TS, Longnecker R. Cleavage and secretion of Epstein-Barr virus glycoprotein gp42 promote membrane fusion with B lymphocytes. J Virol, 2009,83:6664-6672.
8. Wu L, Hutt-Fletcher LM. Point mutations in EBV gH that abrogate or differentially affect B cell and epithelial cell fusion. Virology, 2007,363:148-155.
9. Fingeroth JD, Diamond ME, Sage DR, et al. CD-21 dependent infection of an epithelial cell line, 293, by Epstein-Barr virus. J Virol, 1999,73:2115-2125.
10. Li QX, Young LS, Niedobitek G, et al. Epstein-Barr virus infection and replication in a human epithelial system. Nature, 1992,356:347-350.
11. Borza CM, Morgan AJ, Turk SM, et al. Use of gHgL for attachment of Epstein-Barr virus to epithelial cells compromises infection. J Virol, 2004,78:5007-5014.
12. Jiang R, Gu X, Moore-Medlin TN, et al. Oral dysplasia and squamous cell carcinoma: correlation between increased expression of CD21, Epstein-Barr virus and CK19. Oral Oncol, 2012,48:836-841.
13. Jiang R, Gu X, Nathan C, et al. Laser-capture microdissection of oropharyngeal epithelium indicates restriction of Epstein-Barr virus receptor/CD21 mRNA to tonsil epithelial cells. J Oral Path Med, 2008,37:626-633.
14. Tugizov SM, Berline JW, Palefsky JM. Epstein-Barr virus infection of polarized tongue and nasopharyngeal epithelial cells. Nat Med, 2003,9:307-314.
15. Xiao J, Palefsky JM, Herrera R, et al. The Epstein-Barr virus BMRF- 2 protein facilitates attachment to oral epithelial cells. Virology, 2008,370:430-442.
16. Chesnokova LS, Hutt-Fletcher LM. Fusion of EBV with epithelial cells can be triggered by αvβ5 in addition to αvβ6 and αvβ8 and integrin binding triggers a conformational change in gHgL. J Virol, 2011,85:13214-13223.
17. Chesnokova LS, Nishimura S, Hutt-Fletcher L. Fusion of epithelial cells by Epstein-Barr virus proteins is triggered by binding of viral proteins gHgL to integrins avb6 or avb8. Proc Natl Acad Sci U S A, 2009,106:20464-20469.
18. Chen J, Rowe CL, Jardetzky TS, et al. The KGD motif of Epstein- Barr virus gH/gL is bifunctional, orchestrating infection of B cells and epithelial cells. MBio, 2012,3:e00290-11.
19. Borza C, Hutt-Fletcher LM. Epstein-Barr virus recombinant lacking expression of glycoprotein gp150 infects B cells normally but is enhanced for infection of the epithelial line SVKCR2. J Virol, 1998,72:7577-7582.
20. Miller N, Hutt-Fletcher LM. Epstein-Barr virus enters B cells and epithelial cells by different routes. J Virol, 1992,66:3409-3414.
21. Borza CM, Hutt-Fletcher LM. Alternate replication in B cells and epithelial cells switches tropism of Epstein-Barr virus. Nat Med, 2002,8:594-599.
22. Backovic M, Longnecker R, Jardetzky TS. Structure of a trimeric variant of the Epstein-Barr virus glycoprotein B. Proc Natl Acad Sci U S A, 2009,106:2880-2885.
23. Matsuura H, Kirschner AN, Longnecker R, et al. Crystal structure of the Epstein-Barr virus (EBV) glycoprotein H/glycoprotein L (gH/gL) complex. Proc Natl Acad Sci U S A, 2010,107:22641-22646.
24. Kirschner AN, Sorem J, Longnecker R, et al. Structure of Epstein- Barr virus glycoprotein gp42 suggests a mechanism for triggering receptor-activated virus entry. Structure, 2009,17:223-233.
25. Mullen MM, Haan KM, Longnecker R, et al. Structure of the Epstein- Barr virus gp42 protein bound to the MHC class II receptor HLADR1. Mol Cell, 2002,9:375-385.
26. Backovic M, Jardetzky TS, Longnecker R. Hydrophobic residues that form putative fusion loops of Epstein-Barr virus glycoprotein B are critical for fusion activity. J Virol, 2007,81:9596-9600.
27. Stampfer SD, Heldwein EE. Stuck in the middle: structural insights into the role of gH/gL heterodimer in herpesvirus entry. Curr Opin Virol, 2013,3:13-19.
28. Liu F, Marquardt G, Kirchner AN, et al. Mapping the N-terminal residues of Epstein-Barr virus gp42 that bind gH/gL by using polarization and cell-based fusion assays. J Virol, 2010,84:10375-10385.
29. Chesnokova LS, Ahuja AK, Hutt-Fletcher LM. Glycoproteins gB and gHgL can mediate fusion and entry in trans; heat can act as a partial surrogate for gHgL and trigger a conformational change in gB. J Virol, 2014,88:12193-12201.
30. Silva AL, Omerovic J, Jardetzky TS, et al. Mutational analysis of Epstein-Barr virus glycoprotein gp42 reveals functional domains not involved in receptor binding but required for membrane fusion. J Virol, 2004,78:5946-5956.
31. Chen J, Jardetzky TS, Longnecker R. The large groove found in the gH/gL structure is an important functional domain for Epstein-Barr virus fusion. J Virol, 2013,87:3620-3627.
32. Chowdary TK, Cairns TM, Atanasiu D, et al. Crystal structure of the conserved herpesvirus fusion regulator complex gH-gL. Nat Struct Mol Biol, 2010,17:882-888.
33. Backovic M, DuBois RM, Cockburn JJ, et al. Structure of a core fragment of glycoprotein H from pseudorabies virus in complex with antibody. Proc Natl Acad Sci U S A, 2010,107:22635-22640.
34. Wu L, Borza CM, Hutt-Fletcher LM. Mutations of Epstein-Barr virus gH that are differentially able to support fusion with B cells or epithelial cells. J Virol, 2005,79:10923-10930.
35. Shannon-Lowe C, Baldwin G, Feederle R, et al. Epstein-Barr virus induced B-cell transformation: quantitating events from virus binding to cell outgrowth. J Gen Virol, 2005,86:3009-3019.
36. Valencia SM, Hutt-Fletcher LM. Important but differential roles for actin in trafficking of Epstein-Barr virus in B cells and epithelial cells. J Virol, 2012,86:2-10.
37. Jondal M, Klein G, Oldstone MBA, et al. Surface markers on human B and T lymphocytes. Scand J Immunol, 1976,5:401-410.